Results 191 to 200 of about 101,476 (335)

Erythematous Macular Eruption in an Older Woman [PDF]

, 2019
Kernohan, Neil, McLaughlin, David, Tauro, Sudhir   +2 more
core   +2 more sources

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development

International Journal of Dermatology, EarlyView.
ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease, with a rising incidence in the elderly. BP is associated with multiple triggering factors, including drug exposure. However, evidence in this respect is limited, and the underlying immune mechanisms remain unknown.
Belen de Nicolas‐Ruanes, Carlos Fernandez‐Lozano, Patricia Gutierrez‐Canales, Asuncion Ballester‐Martinez, Natalia Rodriguez‐Otero, Javier Martinez‐Botas, Belén de la Hoz Caballer, Ana Andres‐Martin, Emilio Solano‐Solares, Maria Esther Gomez‐Salazar Lopez‐Silanes, Laura Gisella Diaz‐Montalvo, Diana M. Arrebola, Vivian Lizeth Stewart‐Delcid, Emilio Garcia‐Mouronte, Carlos Azcarraga‐Llobet, Emilio Berna‐Rico, Sonia Ortega‐Sanchez, Montserrat Fernandez‐Guarino   +17 more
wiley   +1 more source

Oncolytic viral therapy for nonmelanoma skin cancer and cutaneous lymphoma - A systematic review. [PDF]

JAAD Int
Ong FLL, Chin DKX, Zhu Y, Oh CC.
europepmc   +1 more source

Primary cutaneous CD8‐positive aggressive epidermotropic cytotoxic T‐cell lymphoma initially demonstrating near‐complete metabolic response to BV‐CHEP

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Tristen Tze Wei Ng, Aaron James Frederiks, Jean‐Frank Iacobelli, Hun Sheng Chuah, Dejan Radeski, Thomas Anthony Delaney   +5 more
wiley   +1 more source

Dupilumab for the Treatment of Cutaneous Immune‐Related Adverse Events: A Systematic Review

International Journal of Dermatology, EarlyView.
ABSTRACT The emergence of immune checkpoint inhibitors has revolutionized the landscape of cancer treatment in the modern era. However, cutaneous immune‐related adverse events (cirAEs) are common, significantly affecting patients' quality of life and often leading to treatment discontinuation, which may compromise oncological outcomes.
Ioannis‐Alexios Koumprentziotis, Aikaterini Niforou, Antonios Tsimpidakis, Christos Nikolaou, Alexander Stratigos, Vasiliki Nikolaou   +5 more
wiley   +1 more source

Is Kaposi sarcoma a novel comorbidity of cutaneous lymphoma? A systematic review of the literature. [PDF]

J Dtsch Dermatol Ges
Moritz RKC, Huynh J, Poch G, Sabat R, Schlaak M, Dobos G.   +5 more
europepmc   +1 more source

Dual genotype in cutaneous T cell lymphoma: Immunoglobulin gene rearrangement in clonal T cell malignancy

, 1989
Yves‐Jean Bignon, P Souteyrand, H. Roger, David Bernard   +3 more
openalex   +1 more source

Clinical outcomes of chlormethine gel in mycosis fungoides affecting “sensitive” areas: A retrospective case series

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Gianluca Tavoletti, Gianluca Avallone, Pamela Vezzoli, Paolo Sena, Angelo V. Marzano, Emilio Berti, Silvia Alberti‐Violetti   +6 more
wiley   +1 more source

Enigmatic Presentation of Primary Cutaneous Lymphoma in a Boy. [PDF]

Plast Reconstr Surg Glob Open
Farhan A, Fakhro A, Burshaid D.
europepmc   +1 more source

Mycosis Fungoides with Dermal Mucin Deposition: An Unusual Variant of the Most Challenging Primary Cutaneous Lymphoma. [PDF]

Case Rep Dermatol, 2021
Filosa A, Simonetti S, Zanelli M, Zizzo M, Stingeni L, Martino G, Collina G, Ascani S.   +7 more
europepmc   +1 more source